Header image
              
Journals 2025
        Platelets, chromogranin A and C-reactive protein predict therapy failure of metastatic hormone-sensitive prostate cancer while miR-375 outperforms PSA in stratifying castration-resistant prostate cancer.        
                  The Journal of Molecular Diagnostics : JMD.                
                  2025,
                
                              S1525-1578(25),
                  
                              00063-7,
                          
                  ISSN: 1525-1578,
                
                
                              PMID: 40139458,